International Circulation: We’re here with Dr. Bonow at TCT-09. Dr. Bonow， will you please share with us the current development of transcatheter aortic valve implantation， also known as TAVI?
国际循环：我们现在在09年TCT会议上采访Dr Bonow。Dr Bonow请您与我们分享一下目前经导管主动脉瓣植入的经验，也就是我们所说的TAVI？

Prof. Robert O. Bonow: Well， this is a very exciting development where we have the opportunity now to not only intervene on patients who are not candidates for surgery but to implant a prosthetic heart valve percutaneously  or through minimally invasive surgical trans-apical approaches.  This is now very exciting because we are talking about intervening on patients who are otherwise inoperable.
So， we are taking the highest risk patients with both a team of surgeons and a team of cardiologists mutually agree are to high risk for surgery and offering them an opportunity a percutaneous or minimally invasive trans-apical valve replacement. 

Prof. Robert O. Bonow: 这是一个非常激动人心的进步，我们现在不仅能够对没有外科适应症的病人进行手术治疗，而且可以经皮植入人工心脏瓣膜，或者通过经心尖微创手术治疗。这的确是令人非常兴奋的，因为我们所谈论的是对无法手术的患者进行介入治疗。 因此，我们会为高风险的患者组建一个外科小组和心脏科小组互相帮助，为患者提供经皮或外科微创经心尖瓣膜置换术。